laurent coudeville
laurent coudeville
Adresse e-mail validée de
Citée par
Citée par
Estimating the global burden of endemic canine rabies
K Hampson, L Coudeville, T Lembo, M Sambo, A Kieffer, M Attlan, ...
PLoS neglected tropical diseases 9 (4), e0003709, 2015
Economic impact of dengue illness in the Americas
DS Shepard, L Coudeville, YA Halasa, B Zambrano, GH Dayan
The American journal of tropical medicine and hygiene 84 (2), 200, 2011
Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model
L Coudeville, F Bailleux, B Riche, F Megas, P Andre, R Ecochard
BMC medical research methodology 10, 1-11, 2010
Health economics of dengue: a systematic literature review and expert panel's assessment
ME Beatty, P Beutels, MI Meltzer, DS Shepard, J Hombach, R Hutubessy, ...
The American journal of tropical medicine and hygiene 84 (3), 473, 2011
Global Alliance for Rabies Control Partners for Rabies Prevention. Estimating the global burden of endemic canine rabies
K Hampson, L Coudeville, T Lembo, M Sambo, A Kieffer, M Attlan, ...
PLoS Negl Trop Dis 9 (4), e0003709, 2015
The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia): a model comparison study
S Flasche, M Jit, I Rodríguez-Barraquer, L Coudeville, M Recker, K Koelle, ...
PLoS medicine 13 (11), e1002181, 2016
Strategies for containing a global influenza pandemic
A Flahault, E Vergu, L Coudeville, RF Grais
Vaccine 24 (44-46), 6751-6755, 2006
The value of varicella vaccination in healthy children: cost–benefit analysis of the situation in France
L Coudeville, F Paree, T Lebrun, J Sailly
Vaccine 17 (2), 142-151, 1999
Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies
L Coudeville, A Van Rie, P Andre
Epidemiology & Infection 136 (5), 604-620, 2008
Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effects
L Coudeville, A Van Rie, D Getsios, JJ Caro, P Crepey, VH Nguyen
PloS one 4 (7), e6284, 2009
Transmission dynamics of the four dengue serotypes in southern Vietnam and the potential impact of vaccination
L Coudeville, GP Garnett
PloS one 7 (12), e51244, 2012
A recombinant live attenuated tetravalent vaccine for the prevention of dengue
B Guy, F Noriega, RL Ochiai, M L’azou, V Delore, A Skipetrova, F Verdier, ...
Expert review of vaccines 16 (7), 671-684, 2017
The economic value of childhood varicella vaccination in France and Germany
L Coudeville, A Brunot, TD Szucs, B Dervaux
Value in Health 8 (3), 209-222, 2005
Cost-effectiveness of dengue vaccination in ten endemic countries
W Zeng, YA Halasa-Rappel, N Baurin, L Coudeville, DS Shepard
Vaccine 36 (3), 413-420, 2018
Varicella vaccination in Italy: an economic evaluation of different scenarios
L Coudeville, A Brunot, C Giaquinto, C Lucioni, B Dervaux
Pharmacoeconomics 22, 839-855, 2004
Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies
L Coudeville, N Baurin, E Vergu
Vaccine 34 (50), 6417-6425, 2016
The cost-effectiveness of universal vaccination of children against hepatitis A in Argentina: results of a dynamic health–economic analysis
E Lopez, R Debbag, L Coudeville, F Baron-Papillon, J Armoni
Journal of gastroenterology 42, 152-160, 2007
Predicted long-term persistence of pertussis antibodies in adolescents after an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular …
F Bailleux, L Coudeville, A Kolenc-Saban, J Bevilacqua, L Barreto, ...
Vaccine 26 (31), 3903-3908, 2008
Tetravalent dengue vaccine reduces symptomatic and asymptomatic dengue virus infections in healthy children and adolescents aged 2–16 years in Asia and Latin America
G Olivera-Botello, L Coudeville, K Fanouillere, B Guy, L Chambonneau, ...
The Journal of infectious diseases 214 (7), 994-1000, 2016
Potential impact of dengue vaccination: Insights from two large-scale phase III trials with a tetravalent dengue vaccine
L Coudeville, N Baurin, M L’Azou, B Guy
Vaccine 34 (50), 6426-6435, 2016
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20